219 related articles for article (PubMed ID: 32321635)
1. Old and new antirheumatic drugs for the treatment of COVID-19.
Benucci M; Damiani A; Infantino M; Manfredi M; Quartuccio L
Joint Bone Spine; 2020 May; 87(3):195-197. PubMed ID: 32321635
[No Abstract] [Full Text] [Related]
2. COVID-19: consider cytokine storm syndromes and immunosuppression.
Mehta P; McAuley DF; Brown M; Sanchez E; Tattersall RS; Manson JJ;
Lancet; 2020 Mar; 395(10229):1033-1034. PubMed ID: 32192578
[No Abstract] [Full Text] [Related]
3. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness.
Martin TR; Wurfel MM; Zanoni I; Ulevitch R
EBioMedicine; 2020 Jul; 57():102836. PubMed ID: 32574958
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
Georgiev T
Rheumatol Int; 2020 May; 40(5):825-826. PubMed ID: 32232552
[No Abstract] [Full Text] [Related]
5. Can beta-adrenergic blockers be used in the treatment of COVID-19?
Vasanthakumar N
Med Hypotheses; 2020 Sep; 142():109809. PubMed ID: 32388480
[No Abstract] [Full Text] [Related]
6. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
7. [De første kliniske data fra RASi-behandlede indlagte patienter med COVID-19 kommer nu, og vi skal ikke ændre medicinering].
Madsen PL
Ugeskr Laeger; 2020 May; 182(20):. PubMed ID: 32400381
[No Abstract] [Full Text] [Related]
8. Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic.
Qian K; Hu S
MAbs; 2020; 12(1):e1782600. PubMed ID: 32546047
[TBL] [Abstract][Full Text] [Related]
9. Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19.
Dabaghian F; Khanavi M; Zarshenas MM
Med Hypotheses; 2020 Oct; 143():109841. PubMed ID: 32425303
[No Abstract] [Full Text] [Related]
10. Drugs and the renin-angiotensin system in covid-19.
Aronson JK; Ferner RE
BMJ; 2020 Apr; 369():m1313. PubMed ID: 32241880
[No Abstract] [Full Text] [Related]
11. Is targeting Akt a viable option to treat advanced-stage COVID-19 patients?
Somanath PR
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L45-L47. PubMed ID: 32519895
[No Abstract] [Full Text] [Related]
12. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.
South AM; Tomlinson L; Edmonston D; Hiremath S; Sparks MA
Nat Rev Nephrol; 2020 Jun; 16(6):305-307. PubMed ID: 32246101
[TBL] [Abstract][Full Text] [Related]
13. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.
Sengupta P; Dutta S
Eur J Contracept Reprod Health Care; 2020 Oct; 25(5):405-406. PubMed ID: 32643968
[No Abstract] [Full Text] [Related]
14. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
[No Abstract] [Full Text] [Related]
15. More questions than answers, and a way ahead.
La Manna G
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281753
[No Abstract] [Full Text] [Related]
16. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
[TBL] [Abstract][Full Text] [Related]
17. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
Huang Y; Xie C; Chen X; Hong Q; Huang H
Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
[No Abstract] [Full Text] [Related]
18. The role of ACEIs/ARBs in COVID-19: Friend or foe?
Zhou Z; Qiu Y; Tao J
Med Hypotheses; 2020 Sep; 142():109810. PubMed ID: 32413701
[No Abstract] [Full Text] [Related]
19. The role of IgA in COVID-19.
Chao YX; Rötzschke O; Tan EK
Brain Behav Immun; 2020 Jul; 87():182-183. PubMed ID: 32454136
[No Abstract] [Full Text] [Related]
20. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
Buszko M; Park JH; Verthelyi D; Sen R; Young HA; Rosenberg AS
Nat Immunol; 2020 Oct; 21(10):1146-1151. PubMed ID: 32855555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
